Register
Study shows faster normalization of platelet count with caplacizumab acquired TTP |
Journal Updates
eMediNexus Coverage from: 
Study shows faster normalization of platelet count with caplacizumab acquired TTP
eMediNexus,  12 January 2019
remove_red_eye 577 Views
#Cardiology #Internal Medicine #Pharmacist

0 Read Comments                

According to results from the HERCULEs trial published online Jan. 9, 2019 in the New England Journal of Medicine, treatment with caplacizumab was associated with faster normalization of the platelet count in patients with acquired thrombotic thrombocytopenic purpura (TTP), a lower incidence of a composite of TTP-related death, recurrence of TTP, or a thromboembolic event during the treatment period; and a lower rate of recurrence of TTP during the trial than pla
To continue reading this article
Or

Continue reading your article with a Emedinexus account..
Free Membership!